Evidence map›Paper›PMID 28772837›Full record

ArticleMaterials (Basel, Switzerland)2017

Rare Earth Element Yttrium Modified Mg-Al-Zn Alloy: Microstructure, Degradation Properties and Hardness.

Long Liu, Fulai Yuan, Mingchun Zhao, Chengde Gao, Pei Feng, Youwen Yang, Sheng Yang, Cijun Shuai

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. SystematicBioactive materials · 2023
    Article
  3. Review
  4. Diclofenac degradation by activating peroxydisulfate via well-dispersed GO/CuEnvironmental science and pollution research international · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Long LiuState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha 410083, China. liulong@csu.edu.cn.
Fulai YuanHealth Management Center, Xiangya Hospital, Central South University, Changsha 410008, China. yuanfulai2017@csu.edu.cn.
Mingchun ZhaoSchool of Material Science and Engineering, Central South University, Changsha 410083, China. mczhao@csu.edu.cn.
Chengde GaoState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha 410083, China. gaochengde@csu.edu.cn.
Pei FengState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha 410083, China. fengpei@csu.edu.cn.
Youwen YangState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha 410083, China. yangyouwen@csu.edu.cn.
Sheng YangHuman Reproduction Center, Shenzhen Hospital of Hongkong University, Shenzhen 518053, China. tobyys2000@aliyun.com.
Cijun ShuaiState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha 410083, China. shuai@csu.edu.cn.
Central South University · CNUniversity of Hong Kong - Shenzhen Hospital · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The overly-fast degradation rates of magnesium-based alloys in the biological environment have limited their applications as biodegradable bone implants. In this study, rare earth element yttrium (Y) was introduced into AZ61 magnesium alloy (Mg-6Al-1Zn wt %) to control the degradation rate by laser rapid melting. The results showed that the degradation rate of AZ61 magnesium alloy was slowed down by adding Y. This was attributed to the reduction of Mg

Indexed as

AZ61 magnesium alloydegradation propertieshardnessmicrostructure

Identifiers

PMID28772837
PMCPMC5459074
OpenAlexW2607855492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.